期刊文献+

^(18)F-FDGPET双时相显像在鉴别良恶性病变中的价值 被引量:3

The value of dual time point ^(18)F-FDG PET imaging for the differentiation between malignant and benign lesions
下载PDF
导出
摘要 目的探讨18F-FDGPET双时相显像在鉴别良、恶性病变中的临床价值。方法对28例原发性肺癌、18例消化系恶性肿瘤、13例其他恶性肿瘤和37例良性病变患者于静脉注射18F-FDG185~370MBq后45min和2.5~3h分别进行早期和延迟双时相PET/CT显像,并对重建后的图像进行定性与定量评价,获得病灶区不同时相的平均SUV(SUVmean)和最大SUV(SUVmax),并以延迟显像SUV值的变化大于10%判断为增高或减低。结果在肺癌组28例中,早期显像24例SUV明显增高(85.7%),延迟显像除1例SUV值无变化外,其余均有不同程度增高,4例早期显像结节处为可疑阳性(SUVmax为1.5~2.1)者,延迟显像3例明显增高,1例SUV未见明显增加,延迟显像阳性率为96.4%;消化系统恶性肿瘤18例,其中17例早期SUV升高(94.4%),1例为阴性,延迟显像18例均增高;其他肿瘤13例,早期均为阳性,延迟显像SUV进一步增高。37例良性病变早期有12例SUV增高(>2.5),延迟显像4例仍为阳性。本文病例早期显像总的的敏感性、特异性、准确性、阳性预测值和阴性预测值分别为91.5%、67.6%、82.3%、68.4%和83.3%;延迟显像分别为98.3%、86.5%、93.8%、92.1%和97.0%。结论18F-FDGPET双时相显像对于鉴别肿瘤的良、恶性有一定价值,几乎所有的早期显像为阳性的恶性肿瘤,延迟显像有进一步摄取增高,但部分良性病灶也具有相同特征。 Objective To assess the clinical value of dual-time point ^18F-FDG PET imaging for differentiating malignant from benign lesions. Methods Twenty-eight patients with primary lung cancer, 18 patients with digestive system carcinoma, 13 patients with other kind of malignant tumors, and 37 patients with benign lesions underwent PET-CT at 2 time points: scan 1 at 45 min and scan 2 at 150-180 min after the intravenous injection of 185-370 MBq ^18 F-FDG. Reconstructed images were evaluated qualitatively and quantitatively. The maximum standardized uptake value (SUVmax) and average SUV (SUV ) within the lesions were calculated for both time points. By adopting a SUV change 〉10% between the first and second scans was as a criterion for increase and decrease. Results Twenty-four of 28 primary lung cancers had SUV〉 2.5 at scan 1. Among them, 23 showed increase uptake and the other one showed no change of SUV in the delayed imaging (scan 2). The other 4 primary lung tumors had SUVs between 1.5 and 2.5 at scan 1 which showed suspected positive, three of whose SUVs increased at time point 2. Seventeen of 18 malignant lesions in digestive system showed SUV〉2.5, the other one showed negative at scan 1, and all showed increase in SUV at scan 2. Of 13 other kinds of tumors, all had SUV〉2.5 at scan 1 and SUVs increased at time point 2. For the benign lesions, 12 showed positive at early and 4 positive in delayed images. The sensitivity, specificity, accuracy, positive and negative predicted value for the early and delayed imaging were 91.5%, 67.6%, 82.3%, 68.4% and 83.3% and 98.3%, 86.5%, 93.8%, 92.1% and 97.0%, respectively. Conclusion These data showed that dual time imaging appeared to be helpful for differentiating benign lesions from malignant lesions. Almost all malignant tumors had SUV〉2.5 at scan 1 and showed further increase at scan 2, but some benign lesions also had this kind of character.
出处 《中国医学影像技术》 CSCD 北大核心 2006年第9期1415-1417,共3页 Chinese Journal of Medical Imaging Technology
关键词 氟18氟代脱氧葡萄糖 正电子发射断层显像 双时相 肿瘤 Fluorodeoxyglucose F18 Positron-emission tomography Dual time point Neoplasms
  • 相关文献

参考文献6

  • 1梁颖慈,唐安戊,徐浩.^(18)F-FDG PET延迟显像鉴别诊断原发性肺癌[J].中华核医学杂志,2004,24(1):27-29. 被引量:37
  • 2Kumar R,Loving VA,Chauhan A,et al.Potential of dual-time-point imaging to improve breast cancer diagnosis with 18F-FDG PET[J].J Nucl Med,2005,46(11):1819-1824.
  • 3Zhuang H,Pourdehnad M,Lambright ES,et al.Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes[J].J Nucl Med,2001,42(9):1412-1417.
  • 4Matthies A,Hickeson M,Cuchiara A,et al.Dual time point 18F-FDG PET for the evaluation of pulmonary nodules[J].J Nucl Med,2002,43(7):871-875.
  • 5Hustinx R,Smith RJ,Benard F,et al.Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography:a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck[J].Eur J Nucl Med,1999,26(10):1345-1348.
  • 6Conrad GR,Sinha P.Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy[J].Nucl Med Commun,2003,4(11):1129-1137.

二级参考文献1

共引文献36

同被引文献46

  • 1杨玲,李连弟,陈育德,Donald Maxwell Parkin.中国肺癌死亡趋势分析及发病、死亡的估计与预测[J].中国肺癌杂志,2005,8(4):274-278. 被引量:168
  • 2吴湖炳,王全师,王明芳,郭晓君,唐刚华.^(18)F-FDGPET显像半定量分析与肺癌病理类型及分期的关系[J].中华核医学杂志,2006,26(1):29-31. 被引量:29
  • 3霍力,周前,吴战宏,肖河,卢朝辉,李汉忠.^(11)C-乙酸盐PET显像在肾脏肿瘤诊断中的作用[J].中华核医学杂志,2006,26(4):205-208. 被引量:20
  • 4Kelloff GJ, Hoffman JM, Johnson B, et al. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development [J]. Clin Cancer Res, 2005, 11 (8): 2785-2808.
  • 5Kumar R, Loving VA, Chauhan A, et al. Potential of dual-timepoint imaging to improve breast cancer diagnosis with ^18F-FDG PET [J]. J Nucl Med, 2005, 46 (11): 1819-1824.
  • 6Lan XL, Zhang YX, Wu ZJ, et al. The value of dual time point ^18F- FDG PET imaging for the differentiation between malignant and benign lesions[J]. Clin Radiol, 2008, 63(7): 756-764.
  • 7Matheja P, Schober O. ^123I-IMT SPET: Introducing another research tool into clinical neuro-oncology [J]. Eur J Nucl Med, 2001, 28 (1): 1-4.
  • 8Jager PL, Vaalburg W, Pruim J, et al. Radiolabeled aminoacids: basic aspects and clinical appacations in oncology [J]. J Nucl Med, 2001, 42 (3): 432-445.
  • 9Goldman S, Levivier M, Pirotte B, et al. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy[J]. J Nucl Med, 1997, 38(9): 1459- 1462.
  • 10Pieterman R, Willemsen A, Appel M, et al. Visualisation and assessment of the protein synthesis rate of lung cancer using carnbon-11 tyrosine and positron emission tomography [J]. Eur J Nucl Med Mol Imaging, 2002, 29 (2): 243-247.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部